Safety and Convenience of Continuous Warfarin Strategy During the Periprocedural Period in Patients Who Underwent Catheter Ablation of Atrial Fibrillation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwak, Jae-Jin | - |
dc.contributor.author | Pak, Hui-Nam | - |
dc.contributor.author | Jang, Jin-Kun | - |
dc.contributor.author | Kim, Sook Kyoung | - |
dc.contributor.author | Park, Jae Hyung | - |
dc.contributor.author | Choi, Jong-Il | - |
dc.contributor.author | Hwang, Chun | - |
dc.contributor.author | Kim, Young-Hoon | - |
dc.date.available | 2020-11-03T05:51:07Z | - |
dc.date.issued | 2010-06 | - |
dc.identifier.issn | 1045-3873 | - |
dc.identifier.issn | 1540-8167 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/14831 | - |
dc.description.abstract | Methods and Results: We compared CW (n = 49) and SH (n = 55, 3 days before RFCA) in 104 patients who underwent RFCA of AF (77 males, 55 +/- 12 years old, paroxysmal AF: persistent AF = 63:41). During the procedure, the activated clotting time (ACT) was maintained between 350 and 400 seconds, and a requirement of H, postablation INR, and periprocedural complications were compared. Results were as follows: (1) in the CW group, the preprocedural INR (1.85 +/- 0.61 vs 1.05 +/- 0.12, P < 0.001) and the proportions of INR > 2.0 after RFCA (1st postprocedure day 61.2% vs 5.5%, P < 0.001; 2nd postprocedure day 83.3% vs 21.8%, P < 0.005) were higher, and the heparin requirement was lower (2012 +/- 998 U/30 minutes vs 2921 +/- 795 U/30 minutes, P < 0.001) than in the SH group. (2) The incidences of hemorrhagic complications (18.2% vs 18.4%, P = NS) or the major bleeding rates (reduced hemoglobin >= 4 g/dL, requiring blood transfusion; 3.6% vs 12.2%, P = NS) were not significantly different in the CW group than in the SH group. Conclusion: The periprocedural CW strategy maintains a more stable INR immediately after AF ablation without increasing hemorrhagic complications compared with the classic strategy of SH. Simple CW can replace SH in an experienced laboratory with a low risk of hemopericardium during AF ablation. (J Cardiovasc Electrophysiol, Vol. 21, pp. 620-625, June 2010). | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | WILEY | - |
dc.title | Safety and Convenience of Continuous Warfarin Strategy During the Periprocedural Period in Patients Who Underwent Catheter Ablation of Atrial Fibrillation | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1111/j.1540-8167.2009.01670.x | - |
dc.identifier.scopusid | 2-s2.0-77952592945 | - |
dc.identifier.wosid | 000277785900005 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, v.21, no.6, pp 620 - 625 | - |
dc.citation.title | JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY | - |
dc.citation.volume | 21 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 620 | - |
dc.citation.endPage | 625 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | PULMONARY-VEIN ABLATION | - |
dc.subject.keywordPlus | ANTICOAGULATION | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | STROKE | - |
dc.subject.keywordPlus | INITIATION | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | SCHEMES | - |
dc.subject.keywordPlus | EVENTS | - |
dc.subject.keywordAuthor | anticoagulation | - |
dc.subject.keywordAuthor | atrial fibrillation | - |
dc.subject.keywordAuthor | warfarin | - |
dc.subject.keywordAuthor | heparin | - |
dc.subject.keywordAuthor | catheter ablation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.